182 related articles for article (PubMed ID: 16443173)
1. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
3. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1993; 71(3-4):263-9. PubMed ID: 8402390
[TBL] [Abstract][Full Text] [Related]
4. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
5. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).
Yuen VG; Orvig C; Thompson KH; McNeill JH
Can J Physiol Pharmacol; 1993; 71(3-4):270-6. PubMed ID: 8402391
[TBL] [Abstract][Full Text] [Related]
6. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.
Torres TP; Catlin RL; Chan R; Fujimoto Y; Sasaki N; Printz RL; Newgard CB; Shiota M
Diabetes; 2009 Jan; 58(1):78-86. PubMed ID: 18952838
[TBL] [Abstract][Full Text] [Related]
7. Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats.
Bhanot S; Bryer-Ash M; Cheung A; McNeill JH
Diabetes; 1994 Jul; 43(7):857-61. PubMed ID: 8013747
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa).
Friedman JE; de Venté JE; Peterson RG; Dohm GL
Am J Physiol; 1991 Dec; 261(6 Pt 1):E782-8. PubMed ID: 1767839
[TBL] [Abstract][Full Text] [Related]
9. Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a).
Slieker LJ; Sundell KL; Heath WF; Osborne HE; Bue J; Manetta J; Sportsman JR
Diabetes; 1992 Feb; 41(2):187-93. PubMed ID: 1733808
[TBL] [Abstract][Full Text] [Related]
10. Low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of Zucker diabetic fatty rats.
MacDonald MJ; Tang J; Polonsky KS
Diabetes; 1996 Nov; 45(11):1626-30. PubMed ID: 8866570
[TBL] [Abstract][Full Text] [Related]
11. The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats.
Estes SK; Shiota C; O'Brien TP; Printz RL; Shiota M
Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E308-E325. PubMed ID: 38265288
[TBL] [Abstract][Full Text] [Related]
12. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
[TBL] [Abstract][Full Text] [Related]
13. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
[TBL] [Abstract][Full Text] [Related]
14. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
Jones HB; Nugent D; Jenkins R
Int J Exp Pathol; 2010 Jun; 91(3):288-301. PubMed ID: 20384904
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
16. Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function.
Paulsen SJ; Vrang N; Larsen LK; Larsen PJ; Jelsing J
J Anat; 2010 Nov; 217(5):624-30. PubMed ID: 20807269
[TBL] [Abstract][Full Text] [Related]
17. Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals.
Wang X; DuBois DC; Sukumaran S; Ayyar V; Jusko WJ; Almon RR
Diabetes Metab Syndr Obes; 2014; 7():531-41. PubMed ID: 25419150
[TBL] [Abstract][Full Text] [Related]
18. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat.
Sturis J; Pugh WL; Tang J; Ostrega DM; Polonsky JS; Polonsky KS
Am J Physiol; 1994 Aug; 267(2 Pt 1):E250-9. PubMed ID: 8074204
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Sakurai H; Tsuchiya K; Nukatsuka M; Sofue M; Kawada J
J Endocrinol; 1990 Sep; 126(3):451-9. PubMed ID: 2170556
[TBL] [Abstract][Full Text] [Related]
20. Effects of fructose feeding on lipid parameters in obese and lean, diabetic and nondiabetic Zucker rats.
Koh ET; Mueller J; Osilesi O; Knehans A; Reiser S
J Nutr; 1985 Oct; 115(10):1274-84. PubMed ID: 3900313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
